The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with advanced melanoma.
 
Saba Shaikh
No Relationships to Disclose
 
Yan Zang
No Relationships to Disclose
 
Janel Hanmer
Research Funding - NICO corporation
 
Hong Wang
No Relationships to Disclose
 
Yan Lin
Research Funding - Bristol-Myers Squibb
 
Diwakar Davar
Honoraria - Array BioPharma; Immunocore; Instil Bio; Merck; Tesaro; Vedanta Biosciences
Consulting or Advisory Role - Instil Bio; Shionogi (I); Vedanta Biosciences
Research Funding - Bristol-Myers Squibb; CellSight Technologies; Checkmate Pharmaceuticals; medpacto; Merck; Tesaro; Zucero Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Application No.: 63/124,231
 
Hassane M. Zarour
Consulting or Advisory Role - Bristol-Myers Squibb; Checkmate Pharmaceuticals; GlaxoSmithKline; Vedanta Biosciences
Research Funding - Checkmate Pharmaceuticals (Inst); Tesaro (Inst)
 
John M. Kirkwood
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Checkmate Pharmaceuticals; Elsevier; Harbour BioMed; Iovance Biotherapeutics; Istari Oncology; Novartis; OncoSec; Pfizer; Scopus BioPharma
Speakers' Bureau - BMS
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Castle Biosciences (Inst); Checkmate Pharmaceuticals (Inst); Immunocore (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Novartis (Inst)
 
Yana G. Najjar
Consulting or Advisory Role - Array BioPharma
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Pfizer/EMD Serono (Inst)